By: Marianne Guenot
The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.
Marianne Guenot is a Science Reporter at Business Insider. She specializes in areas such as artificial intelligence, medicine, healthcare, and natural sciences, covering the intersection of technology and health. Marianne's work has been featured in notable outlets including Business Insider Australia, Yahoo News, and Live Science.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Marianne Guenot's coverage spans scientific, cultural & societal, and entertainment news. She frequently cites data and provides expert commentary on evolving stories within the scientific realm. Pitches to Marianne should emphasize credible sources with expertise in areas such as natural disasters, evolution, space exploration, climate change, ancient discoveries, astronomy, biology; particularly those that involve recent data or unfolding events.
Given her broad coverage of international topics without a specific geographic focus mentioned suggests she is open to insights from various regions around the world.
This information evolves through artificial intelligence and human feedback. Improve this profile .